Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Nicotinamide Phosphoribosyl Transferase Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Nicotinamide Phosphoribosyl Transferase Market Status and Forecast (2016-2027)
      • 1.3.2 Global Nicotinamide Phosphoribosyl Transferase Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Nicotinamide Phosphoribosyl Transferase Supply by Company

    • 2.1 Global Nicotinamide Phosphoribosyl Transferase Sales Volume by Company
    • 2.2 Global Nicotinamide Phosphoribosyl Transferase Sales Value by Company
    • 2.3 Global Nicotinamide Phosphoribosyl Transferase Price by Company
    • 2.4 Nicotinamide Phosphoribosyl Transferase Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Nicotinamide Phosphoribosyl Transferase Market Status by Category

    • 3.1 Nicotinamide Phosphoribosyl Transferase Category Introduction
      • 3.1.1 STF-118804
      • 3.1.2 P7-C3A20
      • 3.1.3 KPT-9274
      • 3.1.4 OT-82
      • 3.1.5 Others
    • 3.2 Global Nicotinamide Phosphoribosyl Transferase Market by Category
      • 3.2.1 Global Nicotinamide Phosphoribosyl Transferase Sales Volume by Category (2016-2021)
      • 3.2.2 Global Nicotinamide Phosphoribosyl Transferase Sales Value by Category (2016-2021)
      • 3.2.3 Global Nicotinamide Phosphoribosyl Transferase Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Nicotinamide Phosphoribosyl Transferase Market Status by End User/Segment

    • 4.1 Nicotinamide Phosphoribosyl Transferase Segment by End User/Segment
      • 4.1.1 Research Center
      • 4.1.2 Hospital
      • 4.1.3 Clinic
    • 4.2 Global Nicotinamide Phosphoribosyl Transferase Market by End User/Segment
      • 4.2.1 Global Nicotinamide Phosphoribosyl Transferase Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Nicotinamide Phosphoribosyl Transferase Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Nicotinamide Phosphoribosyl Transferase Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Nicotinamide Phosphoribosyl Transferase Market Status by Region

    • 5.1 Global Nicotinamide Phosphoribosyl Transferase Market by Region
      • 5.1.1 Global Nicotinamide Phosphoribosyl Transferase Sales Volume by Region
      • 5.1.2 Global Nicotinamide Phosphoribosyl Transferase Sales Value by Region
    • 5.2 North America Nicotinamide Phosphoribosyl Transferase Market Status
    • 5.3 Europe Nicotinamide Phosphoribosyl Transferase Market Status
    • 5.4 Asia Pacific Nicotinamide Phosphoribosyl Transferase Market Status
    • 5.5 Central & South America Nicotinamide Phosphoribosyl Transferase Market Status
    • 5.6 Middle East & Africa Nicotinamide Phosphoribosyl Transferase Market Status

    6 North America Nicotinamide Phosphoribosyl Transferase Market Status

    • 6.1 North America Nicotinamide Phosphoribosyl Transferase Market by Country
      • 6.1.1 North America Nicotinamide Phosphoribosyl Transferase Sales Volume by Country (2016-2021)
      • 6.1.2 North America Nicotinamide Phosphoribosyl Transferase Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Nicotinamide Phosphoribosyl Transferase Market Status

    • 7.1 Europe Nicotinamide Phosphoribosyl Transferase Market by Country
      • 7.1.1 Europe Nicotinamide Phosphoribosyl Transferase Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Nicotinamide Phosphoribosyl Transferase Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Nicotinamide Phosphoribosyl Transferase Market Status

    • 8.1 Asia Pacific Nicotinamide Phosphoribosyl Transferase Market by Country
      • 8.1.1 Asia Pacific Nicotinamide Phosphoribosyl Transferase Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Nicotinamide Phosphoribosyl Transferase Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Nicotinamide Phosphoribosyl Transferase Market Status

    • 9.1 Central & South America Nicotinamide Phosphoribosyl Transferase Market by Country
      • 9.1.1 Central & South America Nicotinamide Phosphoribosyl Transferase Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Nicotinamide Phosphoribosyl Transferase Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Nicotinamide Phosphoribosyl Transferase Market Status

    • 10.1 Middle East & Africa Nicotinamide Phosphoribosyl Transferase Market by Country
      • 10.1.1 Middle East & Africa Nicotinamide Phosphoribosyl Transferase Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Nicotinamide Phosphoribosyl Transferase Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Nicotinamide Phosphoribosyl Transferase Manufacturing Cost Analysis
    • 11.5 Nicotinamide Phosphoribosyl Transferase Sales Channel and Distributors Analysis
      • 11.5.1 Nicotinamide Phosphoribosyl Transferase Sales Channel
      • 11.5.2 Nicotinamide Phosphoribosyl Transferase Distributors
    • 11.6 Nicotinamide Phosphoribosyl Transferase Downstream Major Buyers

    12 Global Nicotinamide Phosphoribosyl Transferase Market Forecast by Category and by End User/Segment

    • 12.1 Global Nicotinamide Phosphoribosyl Transferase Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Nicotinamide Phosphoribosyl Transferase Forecast by Category
      • 12.2.1 Global Nicotinamide Phosphoribosyl Transferase Sales Volume Forecast by Category
      • 12.2.2 Global Nicotinamide Phosphoribosyl Transferase Sales Value Forecast by Category
      • 12.2.3 Global Nicotinamide Phosphoribosyl Transferase Price Forecast by Category
    • 12.3 Global Nicotinamide Phosphoribosyl Transferase Forecast by End User/Segment
      • 12.3.1 Global Nicotinamide Phosphoribosyl Transferase Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Nicotinamide Phosphoribosyl Transferase Sales Value Forecast by End User/Segment
      • 12.3.3 Global Nicotinamide Phosphoribosyl Transferase Price Forecast by End User/Segment

    13 Global Nicotinamide Phosphoribosyl Transferase Market Forecast by Region/Country

    • 13.1 Global Nicotinamide Phosphoribosyl Transferase Market Forecast by Region (2022-2027)
      • 13.1.1 Global Nicotinamide Phosphoribosyl Transferase Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Nicotinamide Phosphoribosyl Transferase Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 OncoTartis, Inc
      • 14.1.1 Company Information
      • 14.1.2 Nicotinamide Phosphoribosyl Transferase Product Introduction
      • 14.1.3 OncoTartis, Inc Nicotinamide Phosphoribosyl Transferase Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Karyopharm Therapeutics, Inc.
      • 14.2.1 Company Information
      • 14.2.2 Nicotinamide Phosphoribosyl Transferase Product Introduction
      • 14.2.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Genentech, Inc.
      • 14.3.1 Company Information
      • 14.3.2 Nicotinamide Phosphoribosyl Transferase Product Introduction
      • 14.3.3 Genentech, Inc. Nicotinamide Phosphoribosyl Transferase Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 FORMA Therapeutics, Inc.
      • 14.4.1 Company Information
      • 14.4.2 Nicotinamide Phosphoribosyl Transferase Product Introduction
      • 14.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyl Transferase Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Calico LLC
      • 14.5.1 Company Information
      • 14.5.2 Nicotinamide Phosphoribosyl Transferase Product Introduction
      • 14.5.3 Calico LLC Nicotinamide Phosphoribosyl Transferase Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Aurigene Discovery Technologies Limited
      • 14.6.1 Company Information
      • 14.6.2 Nicotinamide Phosphoribosyl Transferase Product Introduction
      • 14.6.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyl Transferase Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Angelini Group
      • 14.7.1 Company Information
      • 14.7.2 Nicotinamide Phosphoribosyl Transferase Product Introduction
      • 14.7.3 Angelini Group Nicotinamide Phosphoribosyl Transferase Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Nicotinamide Phosphoribosyl Transferase market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Nicotinamide Phosphoribosyl Transferase market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

        Segmented by Category
        STF-118804
        P7-C3A20
        KPT-9274
        OT-82
        Others

        Segmented by End User/Segment
        Research Center
        Hospital
        Clinic

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        OncoTartis, Inc
        Karyopharm Therapeutics, Inc.
        Genentech, Inc.
        FORMA Therapeutics, Inc.
        Calico LLC
        Aurigene Discovery Technologies Limited
        Angelini Group
        Buy now